Market research
HEXO.TO HEXO Corp
TO CAD Healthcare
Latest close
As of 29 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 39M
- P/E ratio
- Not available
- Analyst target
- 1.39
- Dividend yield
- 0.0%
- Beta
- 2.13
Profile
Instrument facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- ISIN
- CA4283043079
- Market cap
- 39M
- P/E ratio
- Not available
- Analyst target
- 1.39
- Dividend yield
- 0.0%
- Beta
- 2.13
About
About HEXO Corp
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.
Research context
HEXO Corp appears in PyInvesting’s Toronto Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Pharmaceuticals
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the HEXO.TO discussion.
5 years, 6 months ago
HEXO Corp is currently in a long term downtrend where the price is trading 4.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.5.
HEXO Corp's total revenue rose by 93.3% to $33M since the same quarter in the previous year.
Its net income has increased by 93.0% to $-21M since the same quarter in the previous year.
Finally, its free cash flow grew by 83.4% to $-13M since the same quarter in the previous year.
Based on the above factors, HEXO Corp gets an overall score of 4/5.